CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Adamis Pharmaceuticals Corp Company Snapshot
Adamis Pharmaceuticals Corp operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adamis Pharmaceuticals Corp with three other companies in this sector in the United States: International Stem Cell Corporation (2016 sales of $7.17 million ), Geron Corporation ($6.16 million of which 100% was Diagnostic Products), and Apricus Biosciences Inc ($5.76 million ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Adamis Pharmaceuticals Corp
  Stock Performance Chart for Adamis Pharmaceuticals Corp
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 4.43
(Figures in U.S. Dollars)
1 Week -6.8%   13 Weeks 0.6%  
4 Weeks -7.8%   52 Weeks 38.3%  
 
Adamis Pharmaceuticals Corp Key Data:
  Ticker: ADMP Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 6,473,978
(Year Ending Jan 2017).
Employees: 14
  Currency: U.S. Dollars Market Cap: 147,737,395
  Fiscal Yr Ends: December Shares Outstanding: 33,386,982
  Share Type: Common Closely Held Shares: 3,090,211
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.